1/67
Comprehensive vocabulary flashcards covering the eight core modules of NCM 106 Pharmacology: cardiovascular, respiratory, muscular, gastrointestinal, urinary, endocrine, antimicrobial, and obstetric/gynecologic drug therapies.
Antihypertensives
Medications indicated to lower blood pressure, including drug classes such as ACE inhibitors, ARBs, alpha blockers, beta blockers, calcium channel blockers, and diuretics.
Angiotensin-Converting Enzyme (ACE) Inhibitors
Antihypertensive agents that lower blood pressure by preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor (e.g., Lisinopril, Ramipril, Enalapril).
Angiotensin II Receptor Blockers (ARBs)
Antihypertensive agents that lower blood pressure by blocking angiotensin II from binding to receptors, preventing blood vessels from tightening (e.g., Losartan, Valsartan, Telmisartan).
Alpha Blockers
Antihypertensive medications that lower systemic blood pressure by relaxing artery wall muscles (e.g., Prazosin, Doxazosin).
Cardiotonic Agents
Medications that exert a strengthening effect on the myocardium or increase cardiac output, comprising cardiac glycosides and sympathomimetics.
Cardiac Glycosides
Cardiotonic agents that increase myocardial efficiency and contractile force while decreasing heart rate; indicated for congestive heart failure and arrhythmias (e.g., Digoxin).
Sympathomimetic Drugs
Cardiotonic agents that mimic sympathetic nervous system stimulation to engage fight-or-flight responses; indicated for anaphylaxis, cardiac arrest, shock, and hypotension (e.g., Epinephrine, Isoproterenol, Ephedrine).
Phosphodiesterase Inhibitors
Medications that cause vascular smooth muscle to relax and dilate, improving systemic circulation and reducing blood pressure; used in decompensated heart failure and pulmonary hypertension (e.g., Milrinone).
Antiarrhythmic Drugs
Pharmacologic agents used to prevent and manage excessively fast or irregular cardiac rhythms (arrhythmias).
Class I Antiarrhythmics (Sodium Channel Blockers)
Vaughan-Williams antiarrhythmic agents that inhibit the influx of sodium ions across cardiac cell membranes (e.g., Quinidine, Lidocaine, Flecainide).
Class II Antiarrhythmics (Beta Blockers)
Vaughan-Williams antiarrhythmic agents that decrease heart rate by antagonizing adrenergic hormones like adrenaline (e.g., Propranolol, Metoprolol, Atenolol).
Class III Antiarrhythmics (Potassium Channel Blockers)
Vaughan-Williams antiarrhythmic agents that impede potassium movement through cell membranes, prolonging repolarization (e.g., Amiodarone, Sotalol).
Class IV Antiarrhythmics (Nondihydropyridine Calcium Channel Blockers)
Vaughan-Williams antiarrhythmic agents that block L-type calcium channels in cardiac tissue, reducing heart rate and myocardial contractility (e.g., Diltiazem, Verapamil).
Antianginal Drugs
Medications used to prevent or alleviate chest pain caused by myocardial ischemia, functioning by reducing cardiac workload or myocardial oxygen demand.
Nitrates
Antianginal vasodilators that decrease cardiac preload and workload to relieve ischemic chest pain (e.g., Nitroglycerin, Isosorbide dinitrate).
Statins
Lipid-lowering agents that inhibit HMG-CoA reductase, decreasing hepatic cholesterol synthesis and upregulating LDL clearance (e.g., Atorvastatin, Rosuvastatin).
Ezetimibe
A lipid-lowering medication categorized as a cholesterol absorption inhibitor that selectively reduces intestinal absorption of dietary and biliary cholesterol.
Fibrates
Lipid-lowering agents that activate PPAR-α to primarily reduce circulating triglyceride levels (e.g., Fenofibrate, Gemfibrozil).
Anticoagulants
Coagulation-modifying drugs that inhibit clot formation by interfering with various steps of the clotting cascade; indicated for DVT, PE, and thromboembolism prevention (e.g., Heparin, Warfarin, Rivaroxaban).
Antiplatelets
Coagulation-modifying medications that inhibit platelet aggregation to prevent thrombus formation in arterial disease, acute MI, or ischemic stroke (e.g., Aspirin, Clopidogrel).
Thrombolytics
Fibrinolytic drugs that activate the conversion of plasminogen to plasmin to dissolve pre-existing blood clots in acute ischemic stroke, myocardial infarction, or pulmonary embolism (e.g., Alteplase, Tenecteplase).
Iron Preparations (Hematinics)
Supplemental medications that replenish elemental iron stores required for hemoglobin synthesis and red blood cell production in iron-deficiency anemia (e.g., Ferrous sulfate, Ferrous gluconate).
Erythropoiesis-Stimulating Agents (ESAs)
Biologic agents that stimulate bone marrow erythroid progenitor cells to increase red blood cell production in anemia of chronic kidney disease (e.g., Epoetin alfa).
Bronchodilators
Respiratory medications that relax bronchial smooth muscle, dilating the airways to manage bronchospasm in asthma and COPD (e.g., Albuterol).
Inhaled Corticosteroids
Anti-inflammatory respiratory agents that suppress airway mucosal inflammation and edema to control long-term asthma symptoms (e.g., Budesonide, Fluticasone).
Leukotriene Modifiers
Oral agents used for chronic maintenance of asthma and allergic rhinitis that antagonize leukotriene-mediated bronchoconstriction and inflammation (e.g., Montelukast).
Antihistamines
Histamine receptor antagonists that alleviate allergy symptoms like rhinorrhea, sneezing, and pruritus; categorized into sedating first-generation (e.g., Diphenhydramine) and non-sedating second-generation agents (e.g., Cetirizine).
Decongestants
Sympathomimetic agents that reduce nasal passage edema and vascular congestion by constricting dilated mucosal arterioles (e.g., Pseudoephedrine).
Antitussives
Centrally or locally acting pharmacologic agents indicated to suppress dry, nonproductive coughs (e.g., Dextromethorphan, Codeine).
Expectorants
Medications that thin respiratory secretions and stimulate flow, making thick, productive mucus easier to evacuate from the bronchial tree (e.g., Guaifenesin).
Mucolytics
Agents that enzymatically or chemically disrupt the disulfide bonds of mucus to decrease secretion viscosity for easier expectoration (e.g., Acetylcysteine).
Spasticity
A motor disorder characterized by involuntary, velocity-dependent muscle contraction or hypertonia caused by upper motor neuron damage within the brain or spinal cord.
Antispastic Muscle Relaxants
Centrally or peripherally acting agents prescribed to manage hypertonicity and involuntary contractions caused by neurological disorders (e.g., Baclofen, Dantrolene).
Antispasmodic Muscle Relaxants
Medications indicated primarily to alleviate acute musculoskeletal pain, muscle spasms, and myofascial strain (e.g., Carisoprodol, Chlorzoxazone, Cyclobenzaprine).
Dual-Action Muscle Relaxants
Skeletal muscle relaxants that possess both antispastic and antispasmodic clinical activity (specifically Tizanidine and Diazepam).
Neuromuscular Blockers
Pharmacologic paralytics that block transmission at the neuromuscular junction to temporarily abolish skeletal muscle contraction during endotracheal intubation or surgical procedures (e.g., Cisatracurium, Rocuronium).
Drug-Induced Esophagitis
Direct chemical injury and mucosal inflammation of the esophagus occurring when an ingested tablet or capsule becomes physically lodged in the esophageal lumen.
Antiemetics
Medications formulated to prevent or relieve nausea and emesis by targeting specific receptors in the chemoreceptor trigger zone and gastrointestinal tract.
5-HT3 Receptor Antagonists
Antiemetic agents that competitively block serotonin receptors in the peripheral vagal nerve terminals and the chemoreceptor trigger zone; effective for cytotoxic chemotherapy-induced nausea (e.g., Hyoscine context).
Prokinetics (Dopamine Antagonists)
GI medications that block dopamine receptors to stimulate gastrointestinal motility, accelerate gastric emptying, and suppress emesis.
Emetics
Substances that stimulate the central chemoreceptor trigger zone and gastric mucosal receptors to therapeutically induce vomiting (e.g., Apomorphine, Copper Sulfate).
Osmotic Laxatives
Purgatives containing nonabsorbable solutes that draw water into the intestinal lumen by osmotic force, increasing stool mass and triggering peristalsis (e.g., Magnesium hydroxide).
Antacids
Alkaline compounds that chemically neutralize existing gastric hydrochloric acid, increasing intragastric pH and protecting the mucosa (e.g., Sodium bicarbonate).
Proton Pump Inhibitors (PPIs)
Acid-suppressing agents that irreversibly inactivate the H+/K+ ATPase enzyme system—the final common pathway of gastric acid production (e.g., Omeprazole, Lansoprazole).
Antidiarrheals
Medications that stimulate peripheral opioid receptors in the GI tract to decrease propulsive motility and enhance intestinal fluid absorption (e.g., Loperamide, Diphenoxylate).
Histamine-2 (H2) Receptor Antagonists
Antiulcer agents that competitively block histamine receptors on gastric parietal cells to decrease basal and stimulated gastric acid output (e.g., Cimetidine, Ranitidine).
Loop Diuretics
Potent natriuretic diuretics that act on the ascending loop of Henle to cause substantial fluid and sodium excretion (e.g., Furosemide).
Potassium-Sparing Diuretics
Diuretic agents that promote renal sodium and water clearance while conserving potassium ions in the distal nephron (e.g., Spironolactone).
Urinary Tract Analgesic
A compound that exerts a direct topical analgesic/anesthetic effect on inflamed urinary mucosa to alleviate dysuria, urgency, and burning without antibacterial properties (e.g., Phenazopyridine).
Bladder Stimulant
A cholinergic agonist that stimulates parasympathetic muscarinic receptors to force detrusor muscle contraction and facilitate bladder emptying (e.g., Bethanechol).
Desmopressin
A synthetic analogue of antidiuretic hormone (ADH) that enhances renal fluid conservation to treat central diabetes insipidus, nocturnal enuresis, and hemophilia A.
Somatropin
A recombinant form of human growth hormone that stimulates skeletal and somatic tissue growth in pediatric growth hormone deficiencies.
Levothyroxine
A synthetic thyroid hormone (T4) replacement used to treat clinical hypothyroidism and regulate cellular metabolic rate.
Methimazole
An antithyroid drug that inhibits thyroid peroxidase to reduce excessive thyroid hormone synthesis in hyperthyroidism and Graves' disease.
Metformin
A first-line oral biguanide antidiabetic drug that reduces hepatic gluconeogenesis and enhances peripheral tissue sensitivity to insulin.
Alendronate
An oral bisphosphonate that inhibits osteoclast-mediated bone resorption to prevent bone loss in postmenopausal or age-related osteoporosis.
Bactericidal
A classification of antimicrobial agent that directly kills bacterial cells (e.g., Penicillin).
Bacteriostatic
A classification of antimicrobial agent that arrests the growth and replication of bacteria, relying on host immunity for clearance (e.g., Azithromycin).
Uterotonic Agents
Medications that induce or augment myometrial contractions to initiate labor or control postpartum hemorrhage (e.g., Oxytocin, Misoprostol, Carboprost).
Oxytocin
A peptide uterotonic hormone indicated to induce or augment uterine contractions during labor and control uterine atony after delivery.
Carboprost
A prostaglandin F2α analogue uterotonic that produces intense myometrial contractions to manage refractory postpartum hemorrhage.
Antihemorrhagic Agents
Systemic or topical hemostatic medications designed to arrest acute hemorrhage by enhancing physiological clotting mechanisms or constricting local vessels.
Magnesium Sulfate (Obstetric)
A central nervous system depressant and anticonvulsant administered intravenously to prevent and control eclamptic seizures in preeclampsia.
Calcium Gluconate
The specific intravenous antidote administered to counteract life-threatening neuromuscular depression and cardiotoxicity induced by magnesium sulfate overdose.
Tocolytic Agents
Medications that inhibit myometrial contractions to delay preterm labor by 24 to 48 hours, allowing time for fetal lung maturation via antenatal corticosteroids (e.g., Terbutaline, Nifedipine).
Terbutaline
A beta-2 adrenergic agonist tocolytic that relaxes uterine smooth muscle to arrest premature contractions.
Ovulation-Inducing Agents
Pharmacologic treatments (e.g., Letrozole, Clomiphene citrate) that stimulate follicular maturation and ovarian egg release in ovulatory dysfunction or PCOS-related infertility.
Mifepristone
A selective antiprogestogen medication that blocks the action of progesterone to terminate intrauterine pregnancy up to 10 to 12 weeks of gestation when followed by misoprostol.